๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST ยท Real-Time Price ยท USD
0.2870
-0.0189 (-6.18%)
At close: Nov 20, 2026, 4:00 PM EST
0.2798
-0.0072 (-2.51%)
After-hours: Nov 20, 2026, 7:43 PM EST

Tempest Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-20.89-26.58-42.03-29.16-34.64-26.99
Net Income
-40.59-26.26-41.84-29.49-35.71-28.3
Earnings Per Share
-3.38-6.33-19.50-24.87-40.20-97.07
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.97.7130.2739.2331.2351.83
Total Debt
7.268.1415.3720.6622.1118.54
Net Cash (Debt)
-6.36-0.4314.918.579.1233.29
Net Cash Growth
---19.74%103.70%-72.62%103.24%
Net Cash Per Share
-0.53-0.106.9415.6610.26114.18

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-16-26.82-33.03-27.36-31.07-25.96
Capital Expenditures
---0.44-0.17-0.56-0.14
Free Cash Flow
-16-26.82-33.46-27.53-31.63-26.09
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.